featured research

Breast cancer study explores therapy to slow recurrence

Many patients with triple-negative breast cancer (TNBC) have recurrence of their disease after an initial response to chemotherapy because the cancer cells have become resistant to treatment. TNBC has a lower survival rate because of this pattern of resistance and there are no targeted agents to treat this form of breast cancer.

Balser screencap

Dr. Jeffrey R. Balser: Stop the Sequester

The vital partnership between NIH and Vanderbilt – reproduced at universities all around the country – supports thousands of brilliant minds from all around the world. Sequestration will discourage a generation of young people from even considering a career in research.

Gifford fits CI

High Fidelity: Cochlear implant users report dramatically better hearing with new Vanderbilt process

Longtime cochlear implant users are reporting such dramatic improvements in their hearing, thanks to new image-guided programming methods developed by Vanderbilt University researchers.

Potent genetic risk factor for breast cancer identified

Researchers at Vanderbilt University have found a powerful new genetic risk factor for breast cancer.

Capitol dome

Zeppos urges Congress to prioritize research universities and academic medical centers

Chancellor Nicholas S. Zeppos spent Feb. 12 and 13 in Washington, D.C., meeting with congressional leaders and making the case for federal investments in science and engineering research and education.

brain illustration

AstraZeneca, VU collaborate to develop new treatments for major brain disorders

AstraZeneca and Vanderbilt University have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer’s disease and schizophrenia.

1 6 7 8 9 10 13